GE Healthcare, Orange Healthcare and TheraPanacea collaborate with AP-HP and the Thoracic Imaging Society to create an unprecedented database on Covid-19 and develop new tools based on artificial intelligence

  • A clinical research project on the Coronavirus is based on the massive annotation of 10,000 chest scans carried out for suspected Covid-19
  • The data collected will make it possible to constitute an unprecedented database in order to enrich our knowledge of this disease, and to assess the contribution of artificial intelligence in the diagnosis and evaluation of the prognosis.
  • The expertise acquired can be used for the management of other pulmonary diseases.

Paris, France – June 15, 2020. GE Healthcare, Orange Healthcare and TheraPanacea announce a collaboration with the Assistance Publique-Hôpitaux de Paris – AP-HP for the realization of a research project allowing the creation of a database unprecedented around chest imaging in patients suspected of infection with SARS-Cov-2, the virus responsible for Covid-19.

This collaboration aims to support the STOIC project (ThOracic Scanner for the diagnosis of pneumonia linked to Covid-19) led by Professor Marie-Pierre Revel, head of the cardiothoracic imaging unit at Cochin hospital, a study of scope which aims to analyze 10,000 chest scans carried out for suspected Covid-19.

”  The interest of the scanner is to identify early the signs of the disease and to assess the extent  ” explains Professor Revel. “  But it also provides other information on the patient’s state of health, pre-existing to the infection, making it possible to establish a severity score that can be correlated with the clinical course. All of this data is now available and should provide a better understanding of why some individuals develop a severe form of the disease . ”

A group of twenty expert radiologists from the Thoracic Imaging Society mobilized on this project uses a 3D image visualization web application, developed by GE Healthcare on the EDISON ™ platform and deployed by Orange Healthcare via network access and a dedicated infrastructure. hosting of secure health data.

“Cloud hosting services are resilient, scalable and highly secure. They make it possible to deploy projects and manage e-health applications guaranteeing security, business continuity and tailor-made support, responding to the challenges of the scientific community related to the availability and protection of personal health data  ” adds Eric Pieuchot, director of Orange Healthcare.

This software makes it possible to visualize the images in 3D and to annotate the lung lesions from a distance by contouring the areas affected by the virus. It also allows them to provide information on the factors of vascular, pulmonary or overweight comorbidity likely to influence the course of the disease, such as the appearance of the arteries, that of the lungs not affected, or the abundance of fat in the wall. thoracic.

This database will make it possible to develop artificial intelligence solutions, for example in order to quickly and automatically quantify the extent and severity of the lesions, to guide the management of patients, or to evaluate the effectiveness. of the treatments implemented.

“The promises of artificial intelligence in the field of personalized medicine show the importance of working in an ecosystem. With the pooling of expertise, the open and inclusive approach of the STOIC project has made it possible to accelerate a project with high added value, in response to societal expectations ”, explains Baptiste Perrin, R&D Director at GE Healthcare .

From the first data annotated and collected by the consortium, TheraPanacea has developed a pilot integrating artificial intelligence to quantify the disease and establish a short-term prognosis of patients from their lung scans when entering the hospital.

“Artificial intelligence has a crucial role to play in crisis situations such as the one we are experiencing. » Explains Professor Nikos Paragios, President of TheraPanacea. “It must be part of the arsenal of doctors and caregivers to allow them to make the right decisions faster and for more patients, while keeping their critical thinking. “

“This health crisis has forced us to mobilize fully and urgently, and no one has counted their time, whether they are engineers, radiologists, researchers, or project managers managing regulatory aspects », Underlines Professor Revel. “We have discovered models of collaboration that can be replicated for other public health imperatives or emergencies. “

All the data, coming from many Parisian public hospitals, but also from Rennes, Lyon and Strasbourg, will constitute an unprecedented database on Covid-19.

The STOIC project is supported by sponsorship from several companies and foundations, all mobilized by the health emergency: Société Innothera, Société Guerbet, Fondation Centrale Supélec, Fondation de l’AP-HP pour la Recherche.

About GE Healthcare

GE Healthcare is one of the world leaders in medical technology and digital solutions. It enables clinicians to make faster, more relevant decisions through intelligent equipment, data analytics, applications and services. With over 100 years of experience in the healthcare industry and approximately 50,000 employees worldwide, the company is at the center of an ecosystem that works for precision medicine.

Present in France since 1987 with 2,800 employees today, it is a player firmly anchored in France through its industrial footprint, its R&D and production center in Buc in the Yvelines and research partnerships with companies and French research centers.

About Orange Healthcare

Since 2007, Orange Healthcare has been working with the main healthcare players to develop solutions adapted to the healthcare sectors, thus helping to support them in their digital transformation throughout the entire life cycle of their data: collection, transport, protection, storage and processing, analysis and sharing.

Within Orange Business Services, Orange Healthcare has all the technological know-how to offer solutions that are simple, reliable and efficient, thus helping to provide innovative responses to the needs of patients and healthcare professionals. Because they make it possible to optimize practices while ensuring the quality and equality of access to care, new technologies indeed play an essential role in the modernization and improvement of health systems. Orange Healthcare is certified as a healthcare data host (ISO 27001 and HDS certifications) for all activities in the certification reference system. With the acquisition in early 2018 of Enovacom, a French software publisher, Orange Business Services has enriched its offer in the interoperability of health systems. On the strength of this alliance of technologies and skills, Orange Healthcare & Enovacom offer a comprehensive response and support tailored to players in the healthcare ecosystem.

About TheraPanacea

TheraPanacea is a medical technology company created in 2017, with expertise in medical imaging, advanced mathematics and data sciences, which develops and markets a new generation of intelligent software addressing the diagnosis, prognosis and treatment in oncology, and in particular in radiotherapy. oncology. Its first ART-Plan ™ software product for radiotherapy has been available on the European market since 2019.

Since its creation, TheraPanacea has won prestigious distinctions and prizes including the European Research Council (ERC) Proof of Concept grant (2016), the Digital Innovation Competition (BPI), the Grands Prix d’Innovation de la Ville de Paris in Health category (2017), the 1st AI Challenge prize in the Paris region (2018) and the H2020 – SME Instrument Phase 2 prize (2019) rewarding the most disruptive European companies in their market.

About the AP-HP The leading hospital and university center (CHU) in Europe, the AP-HP and its 39 hospitals are organized into six university hospital groups (AP-HP. Center – University of Paris; AP-HP. Sorbonne University; AP-HP North – University of Paris; AP-HP. Paris Saclay University; AP-HP. Henri Mondor and AP-HP University Hospitals. Paris Seine-Saint-Denis University Hospitals) and are organized around five universities in the Ile-de-France region. Closely linked to major research organizations, the AP-HP has three world-class hospital-university institutes (ICM, ICAN, IMAGINE) and the largest French health data warehouse (EDS). A major player in applied research and innovation in health, AP-HP holds a portfolio of 650 active patents, its clinician-researchers sign nearly 9,000 scientific publications each year and more than 4,000 research projects are currently under development, all promoters combined. The AP-HP also created the AP-HP Foundation for Research in 2015 to support biomedical and health research carried out in all of its hospitals.

Press contacts:

Caroline Nouveau, GE Healthcare 

06 20 49 49 25 |

Catherine Martineau-Huynh, TheraPanacea

c.huynh@therapanacea. had

Caroline Cellier, Orange Business Services

06 07 25 00 06 |

AP-HP press service

01 40 27 30 00 |